Circadian repressors CRY1 and CRY2 broadly interact with nuclear receptors and modulate transcriptional activity

Nuclear hormone receptors (NRs) regulate physiology by sensing lipophilic ligands and adapting cellular transcription appropriately. A growing understanding of the impact of circadian clocks on mammalian transcription has sparked interest in the interregulation of transcriptional programs. Mammalian...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 114; no. 33; pp. 8776 - 8781
Main Authors Kriebs, Anna, Jordan, Sabine D., Soto, Erin, Henriksson, Emma, Sandate, Colby R., Vaughan, Megan E., Chan, Alanna B., Duglan, Drew, Papp, Stephanie J., Huber, Anne-Laure, Afetian, Megan E., Yu, Ruth T., Zhao, Xuan, Downes, Michael, Evans, Ronald M., Lamia, Katja A.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 15.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nuclear hormone receptors (NRs) regulate physiology by sensing lipophilic ligands and adapting cellular transcription appropriately. A growing understanding of the impact of circadian clocks on mammalian transcription has sparked interest in the interregulation of transcriptional programs. Mammalian clocks are based on a transcriptional feedback loop featuring the transcriptional activators circadian locomotor output cycles kaput (CLOCK) and brain and muscle ARNT-like 1 (BMAL1), and transcriptional repressors cryptochrome (CRY) and period (PER). CRY1 and CRY2 bind independently of other core clock factors to many genomic sites, which are enriched for NR recognition motifs. Here we report that CRY1/2 serve as corepressors for many NRs, indicating a new facet of circadian control of NR-mediated regulation of metabolism and physiology, and specifically contribute to diurnal modulation of drug metabolism.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by Steven A. Kliewer, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, and approved July 3, 2017 (received for review March 24, 2017)
Author contributions: A.K., R.M.E., and K.A.L. designed research; A.K., S.D.J., E.S., E.H., C.R.S., M.E.V., A.B.C., D.D., S.J.P., A.-L.H., M.E.A., and K.A.L. performed research; A.K., X.Z., and M.D. contributed new reagents/analytic tools; A.K., R.T.Y., and K.A.L. analyzed data; and A.K. and K.A.L. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1704955114